Dr. Reddy’s Labs made an agreement with Gilead to manufacture COVID-19 drug
Dr. Reddy’s Labs: It is one of the largest multinational pharmaceutical companies in India located in Hyderabad. The company founded by Anji Reddy, who works as Indian drugs and pharmaceuticals limited. The company manufactures and markets different pharmaceuticals in India. However, the company manufactures almost 190 medications, 60 APIs for drugs, diagnostic kits, and biotechnology products.
Meanwhile, the company on Saturday, June 13th said it made an agreement or contract with US-based company Gilead Sciences. The deal is to manufacture and market Remdesivir as a potential treatment for COVID-19 across the world. The medicine markets in 127 countries including India.
As per the reports, the agreement includes that the US-based drug company will grant Hyderabad based drug makers to register and manufacture its “Remdesvir drug” in 127 countries. However, the company will receive technology and equipment from the US company Gilead to manufacture COVID-19 drugs.
On the other side, the company will need to get regulatory approvals from the respective companies in order to market. Whereas, Remdesivir is an investigational antiviral therapy manufactured by the US company Gilead. While the company gets Emergency Use Authorisation (EUA) from US Food and Drug Administration (USFDA) to treat the COVID-19 pandemic.
However, Dr. Reddy’s Labs Limited on Friday reported a bearish trend in the stock market. The company lost 51.60 points with a 1.27% decrease and reached 4,006.00 INR. While in BSE, the company lost 46.65 points with a 1.15% decrease and reached 4,008.95 INR.
Stock Market June 12th:
On Monday, both Sensex and Nifty reported a bullish trend in the stock market. The Sensex is trading above 33,700 levels, and Nifty is trading above 9,972.90 levels in the stock market. The Sensex gained 242.52 points with a 0.72% increase and reached a 33,780.89 level. While Nifty gained 70.90 points with a 0.72% increase and reached 9,972.90 level.
On the other side, the number of coronavirus cases in India reached 3,08,993 as of Saturday, June 13th, and deaths reached 8,884.
In the border market, the S&P BSE Smallcap index reported a bullish trend in the stock market on Friday. It gained 14.85 points with a 0.13% increase and reached an 11,845.27 level. The S&P BSE Midcap index gained 119.57 points with a 0.96% increase and reached a 12,600.15 level. While Nifty Bank gained 70.90 with a 0.72% increase and reached 9,972.90 level.
Top Gainers on June 12th: M&M, Bharti Infratel, Shree Cements, Bajaj Finance, and Hero Motocorp are the top gainers in today’s stock market
Top Losers on June 12th: Zee Entertainment, ONGC, Tech Mahindra, Power Grid Corp, and Wipro are the top losers in today’s stock market.
